SARS-CoV-2 nucleocapsid induces hyperinflammation and vascular leakage through the Toll-like receptor signaling axis in macrophages
Science Advances · 07.08.2026 · 12 (32)
DOI: 10.1126/sciadv.aea2780 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, erschienen am 07.08.2026. Verfasst von Zhenlan Yao und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Immunology and Molecular Genetics, University of California, Los Angeles, Los Angeles, CA 90095, USA. Hauptthemen laut MEDLINE: Macrophages, SARS-CoV-2, COVID-19, Toll-Like Receptors. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 88 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, National Institute of Allergy and Infectious Diseases, W.M. Keck Foundation.
Abstract (Originalsprache)
A substantial proportion of hospitalized COVID-19 patients require ICU admission, often associated with an imbalance between antiviral responses and inflammatory signaling leading to uncontrolled cytokine secretion. The SARS-CoV-2 nucleocapsid (N) protein is a known immune antagonist, but its role in macrophage-driven cytokine storms is unclear. We demonstrate that N functions in a stimulus-specific manner, specifically amplifying extracellular and dampening intracellular RNA sensing. Moreover, we show that this is a conserved feature of pathogenic betacoronaviruses through distinct mechanisms. Our interaction networks with SARS-CoV-2 variant N proteins suggest that the Delta variant N drives inflammation through interactions with several proteins, most notably, cGAS. Profiling of secreted cytokines revealed that N disrupts the secretome in a variant-specific manner. Most notably, we found that supernatants from the Delta variant N–expressing macrophages dramatically disrupt heart endothelial barriers, implicating N in COVID-19–associated cardiac complications. Our findings highlight N-mediated immune imbalance as a driver of severe COVID-19 and identify N as a promising therapeutic target to mitigate hyperinflammation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Microbiology, Immunology and Molecular Genetics, University of California, Los Angeles, Los Angeles, CA 90095, USA.
- Molecular Biology Institute, University of California, Los Angeles, Los Angeles, CA 90095, USA.
- Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA.
- Department of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA.
- Department for Bioengineering, Samueli School of Engineering, University of California, Los Angeles, Los Angeles, CA 90095, USA.
- Center for Infection Biology, School of Basic Medical Sciences, Tsinghua University, Beijing, China.
ORCID-Profile: Zhenlan Yao, Pablo A Alvarez, Yennifer Delgado, David W Buchholz, David Austin, Anne K Zaiss, Vaithilingaraja Arumugaswami, Jeffrey J Hsu, Robert Damoiseaux, Hector C Aguilar, Mehdi Bouhaddou, Alexander Hoffmann, Melody M H Li
Förderung
- NIAID NIH HHS
- National Institute of Allergy and Infectious Diseases
- W.M. Keck Foundation
- American Heart Association
- Ruth L. Kirschstein National Research Service
- UCLA Microbiology, Immunology and Molecular Genetics
- UCLA DGSOM - Broad Stem Cell Research Center
- Jonsson Comprehensive Cancer Center-Broad Stem Cell Research Center
Zitieren
APA
Yao, Z., Alvarez, P. A., Chavez, C., Delgado, Y., Kaushal, P., Buchholz, D. W., Austin, D., Li, Q., Yu, Y., Zaiss, A. K., Arumugaswami, V., Ding, Q., Hsu, J. J., Damoiseaux, R., Aguilar, H. C., Bouhaddou, M., Hoffmann, A., & Li, M. M. H. (2026). SARS-CoV-2 nucleocapsid induces hyperinflammation and vascular leakage through the Toll-like receptor signaling axis in macrophages. Science Advances, 12(32). https://doi.org/10.1126/sciadv.aea2780
Vancouver
Yao Z, Alvarez PA, Chavez C, Delgado Y, Kaushal P, Buchholz DW, et al. SARS-CoV-2 nucleocapsid induces hyperinflammation and vascular leakage through the Toll-like receptor signaling axis in macrophages. Science Advances. 2026;12(32). doi:10.1126/sciadv.aea2780
BibTeX
@article{Yao2026,
author = {Yao, Zhenlan and Alvarez, Pablo A and Chavez, Carolina and Delgado, Yennifer and Kaushal, Prashant and Buchholz, David W and Austin, David and Li, Qian and Yu, Yanying and Zaiss, Anne K and Arumugaswami, Vaithilingaraja and Ding, Qiang and Hsu, Jeffrey J and Damoiseaux, Robert and Aguilar, Hector C and Bouhaddou, Mehdi and Hoffmann, Alexander and Li, Melody M H},
title = {SARS-CoV-2 nucleocapsid induces hyperinflammation and vascular leakage through the Toll-like receptor signaling axis in macrophages},
journal = {Science Advances},
year = {2026},
volume = {12},
number = {32},
doi = {10.1126/sciadv.aea2780}
}
EUVIMED